TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biolamina AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Turnover |
20,642
|
15,629
|
11,821 |
| Financial expenses |
196
|
42
|
51 |
| Earnings before taxes |
1,378
|
859
|
422 |
| EBITDA |
2,194
|
1,396
|
386 |
| Total assets |
15,495
|
12,758
|
12,125 |
| Current assets |
12,261
|
9,623
|
7,808 |
| Current liabilities |
3,775
|
4,113
|
3,679 |
| Equity capital |
9,402
|
8,645
|
7,893 |
| - share capital |
20
|
21
|
21 |
| Employees (average) |
94
|
69
|
45 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Solvency |
60.7%
|
67.8%
|
65.1% |
| Turnover per employee |
220
|
227
|
263 |
| Profit as a percentage of turnover |
6.7%
|
5.5%
|
3.6% |
| Return on assets (ROA) |
10.2%
|
7.1%
|
3.9% |
| Current ratio |
324.8%
|
234.0%
|
212.2% |
| Return on equity (ROE) |
14.7%
|
9.9%
|
5.3% |
| Change turnover | |||
| Change turnover % |
32%
|
81% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
53%
|
32% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.